Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
J Infect Dis ; 219(11): 1743-1748, 2019 05 05.
Artículo en Inglés | MEDLINE | ID: mdl-30590710

RESUMEN

The expression and activity of main inflammasome components in monocytes from successfully treated human immunodeficiency virus (HIV)-positive patients are poorly studied. Thus, we enrolled 18 patients with a low and 17 with a normal ratio of CD4+ T cells to CD8+ T cells and 11 healthy donors. We found that patients with a low ratio had decreased CCR2 expression among classical and intermediate monocytes and increased CCR5 expression among classical monocytes, compared with patients with a normal ratio. Patients with a low ratio also had higher NAIP and PYCARD messenger RNA levels after lipopolysaccharide stimulation, suggesting an altered ability to control immune activation that could affect their immune reconstitution.


Asunto(s)
Proteínas Adaptadoras de Señalización CARD/genética , Infecciones por VIH/inmunología , Inflamasomas/inmunología , Interleucina-18/genética , Interleucina-1beta/genética , Proteína Inhibidora de la Apoptosis Neuronal/genética , Adulto , Anciano , Linfocitos T CD4-Positivos/inmunología , Linfocitos T CD8-positivos/inmunología , Femenino , Regulación de la Expresión Génica , Infecciones por VIH/virología , Seropositividad para VIH , Humanos , Masculino , Persona de Mediana Edad , Monocitos/inmunología
2.
Methods ; 134-135: 98-105, 2018 02 01.
Artículo en Inglés | MEDLINE | ID: mdl-29197654

RESUMEN

Combined antiretroviral therapy (cART) blocks different steps of HIV replication and maintains plasma viral RNA at undetectable levels. The virus can remain in long-living cells and create a reservoir where HIV can restart replicating after cART discontinuation. A persistent viral production triggers and maintains a persistent immune activation, which is a well-known feature of chronic HIV infection, and contributes either to precocious aging, or to the increased incidence of morbidity and mortality of HIV positive patients. The new frontier of the treatment of HIV infection is nowadays eradication of the virus from all host cells and tissues. For this reason, it is crucial to have a clear and precise idea of where the virus hides, and which are the cells that keep it silent. Important efforts have been made to improve the detection of viral reservoirs, and new techniques are now giving the opportunity to characterize viral reservoirs. Among these techniques, a strategic approach based upon cell sorting and droplet digital PCR (ddPCR) is opening new horizons and opportunities of research. This review provides an overview of the methods that combine cell sorting and ddPCR for the quantification of HIV DNA in different cell types, and for the detection of its maintenance.


Asunto(s)
Citometría de Flujo/métodos , Infecciones por VIH/virología , Reacción en Cadena de la Polimerasa/métodos , Replicación Viral/genética , Terapia Antirretroviral Altamente Activa , Separación Celular/métodos , ADN Viral/genética , ADN Viral/aislamiento & purificación , Infecciones por VIH/tratamiento farmacológico , Infecciones por VIH/inmunología , VIH-1/aislamiento & purificación , VIH-1/patogenicidad , Humanos , ARN Viral/genética , ARN Viral/aislamiento & purificación
3.
Methods ; 134-135: 3-10, 2018 02 01.
Artículo en Inglés | MEDLINE | ID: mdl-29133210

RESUMEN

Circulating endothelial cells (CECs) detach from the intima monolayer after endothelial damages. Their circulating endothelial progenitors (CEPs) represent less than 0.01% of nucleated blood cells. Increased levels of CECs and CEPs have been detected in patients with several types of cancer, suggesting that they could be a useful blood-based marker for detecting a tumor, or for monitoring its clinical course. However, their routine monitoring is time consuming and technically challenging. Here, we present a flow cytometry method for quantifying such cells in a cohort of patients with hemangioblastoma (HB). HB is a rare benign tumor, responsible for 1-2.5% of primary intracranial tumors and up to 10% of spinal cord tumors, and for which no tools are available to predict the onset or recurrence in patients undergoing surgical removal of tumor mass. This method allowed us to accurately quantifying CEC and CEP before and after surgery. CEPs are present at high levels in HB patients than control before intervention, and decrease after tumor removal, suggesting that their percentage could represent a valid tool to monitor the disease onset and recurrence.


Asunto(s)
Biomarcadores de Tumor/sangre , Citometría de Flujo , Hemangioblastoma/sangre , Células Neoplásicas Circulantes/patología , Adolescente , Adulto , Anciano , Niño , Células Endoteliales/patología , Femenino , Hemangioblastoma/patología , Humanos , Masculino , Persona de Mediana Edad , Adulto Joven
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...